Research team assesses addition of complement inhibitor drug to immunotherapy for ovarian cancer
Researchers at Roswell Park Comprehensive Cancer Center, USA, have launched a phase 2 clinical trial…
Researchers at Roswell Park Comprehensive Cancer Center, USA, have launched a phase 2 clinical trial…
New immunotherapy treatments offer a remarkable chance for survival for patients with advanced melanoma and…